Monte Rosa Therapeutics, Inc. (GLUE) reported Q4 Revenue

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. SPY
5. NVDA
6. WYFI
7. STUB
8. EAT
9. BTGO
10. GO

Go back to Monte Rosa Therapeutics, Inc. (GLUE) reported Q4 Revenue
(NASDAQ: GLUE) Delayed: 15.84 -0.11 (0.69%)
Previous Close $15.95    52 Week High $ 
Open $16.08    52 Week Low $ 
Day High $16.25    P/E N/A 
Day Low $15.79    EPS $ 
Volume 682,350